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Summary.-Separate and combined effects of bleomycin and X-rays on rates of
uptake of [14C]thymidine into Ehrlich ascites cells were assessed for extracellular
drug concentrations of 12 ,um (20,ug/ml) and radiation doses of 2*5 krad. Rates of
DNA synthesis were followed by monitoring the activity of the acid-insoluble portion
of the asynchronous culture. The 14C activity of the acid-soluble pool was assessed in
determining the rate of passage of 14C-TdR across the cell membrane.
The results reveal that whilst the effects of each agent on TdR uptake rates are
markedly different, they both inhibit DNA synthesis.
Combined studies with both agents, 2-5 krad X-rays plus 20,g/ml bleomycin
before, simultaneously or after exposure to X-rays, produced additive or less than
additive effects on rates of incorporation of TdR into DNA. However, when the drug
dose is split 2 x 10,g/ml before and after exposure to 2 5 krad X-rays, a synergistic
effect on inhibition of DNA synthesis is observed.
BLEOMYCINS are a group of basic
glycopeptides produced by a strain of
Streptomyces verticillus (Umezawa et al.,
1966). Commercially available Bleomycin
(Lundbeck) is composed basically of
bleomycins A2 and B2, and exhibits
antibacterial and antineoplastic activity
in vitro and in vivo (Umezawa et al.,
1966; Ishizuka et al., 1967). Bleomycin
shows specific affinity for squamous cells
(Umezawa et al., 1972; Ichikawa et al.,
1970), making the compound especially
useful in the treatment of human
squamous carcinomas, which are generally
unresponsive to most antineoplastic drugs
(Grey and Michaels, 1972; Halnan et al.,
1972).
Bleomycin is known to inhibit DNA
synthesis (Kunimoto, Hori and Umezawa,
1967; Suzuki et al., 1968), cause DNA-
strand scission (Fujiwara and Kondo,
1973; Terasima, Yasukawa and Umezawa,
1970) in vitro and in vivo, and to degrade
single- and double-stranded DNA in
vitro. This latter property has also been
observed using synthetic deoxyribo-
polymers (Suzuki, Nagai and Yamaki,
1969; Haidle, 1971). Degradation involves
release of free bases, damage to the
deoxyribose moiety and rupture of phos-
phodiester bonds, resulting in fragmen-
tation of DNA (Haidle, Weiss and Kuo,
1972; Kuo and Haidle, 1973).
The similarity of action of bleomycin
and ionizing radiation, both at a molecular
level involving DNA, and at a cellular
level, as observed both by the sensitivity
of cells in mitosis to bleomycin (Haidle,
Kuo and Weiss, 1972) and by induced
mitotic delay (Haidle and Bearden, 1975),
has aroused considerable interest in pos-
sible applications of the antibiotic in
conjunction with radiation in tumour
therapy.
Several reports have appeared in the
literature involving combined schedules
ofradiation and bleomycin on cell survival
in vitro and on tumour growth in vivo.
Bleehen, Gillies and Twentyman (1974)
reported evidence of synergistic actionSYNERGISM OF BLEOMYCIN AND X-RAYS
of X-rays and bleomycin on the sur-
vival of E. coli B/r but were unable
to find evidence of a potentiating effect
on survival of EMT6 cells. Wharam
et al. (1973) reported sensitization of
EMT6 cells to ionizing radiation by the
drug, observed as a reduction of the
shoulder on cell survival curves produced
from combined experiments. Both papers
suggested that the drug interferes with
repair of radiation-induced sublethal
damage. An alternative suggestion (Mat-
suzawa et al., 1972) involved the concept
of a drug-reduced capacity of cells to
accumulate sublethal damage.
Jorgensen (1972), using mouse epider-
moid carcinoma induced by methyl-
cholanthrene, reported a synergistic effect
on tumour regression for simultaneous
treatment, but found no potentiation
when intermittent drug and radiation
schedules wero used.
In view of the discrepancy in the
literature regarding the synergistic action
of bleomycin and radiation it was decided
to study the action of bleomycin and
radiation under various combined
schedules, using one measurable system
inhibited by both agents-DNA synthesis
in vitro.
MATERIALS AND METHODS
Ehrlich tetraploid ascites tumour (EAT)
cells were removed from the peritoneum of an
infected mouse and suspended in Eagle's
minimum essential medium with Hepes
buffer. The medium was supplemented with
25% calf serum, 5 x 104 units of penicillin
and 0.05% streptomycin. The cell suspension
was diluted to give a final cell concn. of
2-3 x 106 cells/ml.
Copper-free bleomycin (Lundbeck Ltd)
was used in the present experiments. The
bleomycin solution was usually made immedi-
ately before use by dissolving the bleomycin
in sterile distilled water to give final concn.
of 20-40 ,ug bleomycin/ml media (12-24 ltM).
Irra4iation of the samples was carried out
using a Marconi deep-therapy X-ray machine
calibrated at 250 kV and 15 mA without filter,
using a Baldwin-Farmer dosimeter.
The dose rate to the centre of the 10-ml
6
suspension, placed 5 cm from the tube face,
was 2-5 krad/min. The cells were irradiated
in air at room temperature.
The irradiated suspension were subse-
quently incubated in a shaking water bath
at 370C.
In the bleomycin experiments a contact
of 30 min with the cell suspension 4t 37°C
was required for bleomycin effect to reach
maximum for a particular concentration
before the addition of the tracer.
In the combined treatment the suspensions
were treated with the drug, irradiated and
incubated at 370C as shown in Table II.
Experimental procedure.-O-2 ,uCi of [C14]-
TdR sp. act. 62 mCi/mM (TdR concn. w
0-003 jM) from the Radiochemical Centre,
Amersham, was added to 10 ml suspension
following each treatment. Aliquots ofthe cell
suspension were removed at 5 and 45 min
of incubation with the tracer and immedi-
ately centrifuged. The supernatant was
discarded and the packed cell pellet was
washed with isotonic saline and centrifuged
to remove any extracellular activity. The
pellet was lysed with ice-cold 2% trichloro-
acetic acid (TCA). The lysed cells were centri-
fuged and the supernatant retained for
estimation of 14C activity of the intracellular
pool. The lysed cell precipitate was washed
twice with ice-cold absolute alcohol to remove
[14C]-TdR that might be attached to intra-
cellular lipid, and the final pellet dispersed
in PCS scintillation fluid (Amersham, Searle).
Any radioactivity associated with this
dispersion should have originated from TdR
incorporation into DNA. The 14C content of
the samples was determined in a Nuclear
Enterprises 6500 liquid scintillation counter.
Counting efficiency was 78% as determined
by external standard, prior to quench
corrections being applied on the basis of
internal standards.
RESULTS
Experiments were carried out to inves-
tigate the effects of ionizing radiation
and bleomycin individually on the rate of
incorporation of the 14C label into the
intracellular pool over a period of 45 min
at 37°C after the addition of the tracer.
Results from concurrent studies (Kwok
and Chapman, 1977) indicate that phos-
phorylation of the nucleoside TdR is a
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rapid process in relation to transport
time, and that approximately 80% of
the activity of the intracellular pool is
made up of phosphorylated TdR, mostly
TDP and TTP, whilst the remaining 20%
is TdR and some thymine.
The results shown in Fig. 1 indicate






FIG. 2. Radiation-induced depression of
initial uptake rates of [14C]-TdR into the
TCA-soluble pool over the first 5 min of








FIo. 1.-Influence of 12 ,ua
(BLEO) or 5 krad X-rays on
of [14C]-TdR (extracellular
0-02 ,uCi/ml) into the TCA-s4
EAT cells. Activity estimat
times after irradiation of (
standard pre-incubation pe
in contact withBLEO. Error
standard errors.
radioactivity of the intrac
thymine nucleosides and nu4
bleomycin appears to enha
the pool. Standard errors
from 5 experiments each
duplicate. Other points re
with insufficient data to ca
standard errors. The sign
radiation and bleomycin e
established only for val
These results may refle(
transport kinetics of TdR
and changes in rates of ir
[14C]TTP into DNA.
The influence of X-re
uptake rates over the first
intracellular pool was inv
the dose range 1-2-7 kra4
shown in Fig. 2 indicati
dose-dependent depressior:
over this period of relatively rapid uptake
of TdR.
A similar series of experiments was
carried out for 3 different concentrations
of bleomycin (Table I). The drug appears ,30 40 4'5 to enhance the rate of [14C]TdR uptake,
independently of dose, over the range
~M bleomycin studied.
the transport
concentration The effects of separate and combined
oluble pool in treatment using bleomycin and X-rays on
led at various the 140 activity of the acid-insoluble
cells or after
nriod (30 min) portion were investigated (Table II).
bars represent Both single and split drug doses were
used in experiments with the drug alone
or in conjunction with radiation.
cellular
pool of The results for drug alone reveal that
cleotides,whilst splitting the extracellular drug concen-
nce the size of tration to 2 x 6 ,uM (2 X 10 ,tg/ml) rather
represent data than one concentration of 12 pM did not
carried out in produce significantly different results for
present means the depression of incorporation of radio-
lculate reliable active label into DNA. It is also observed
ificance of the that exposure of the cells to 2i5 krad
flects has been together with a single drug dose, given




TABLE I.-Effects of Bleomycin Concen-
tration on Intracellular Acid-soluble 1
ays on initial Activity
5 min into the ,IM Bleomycin % Increase above control
restigated over 6 12.8±2
Id. The results 12 10-0±1-7
e a non-linear 24 12-0±2
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TABLE II.-Decreased Incorporation of [14C] TdR into Acid-insoluble Portion: Various
Treatment Schedules
Treatment % of control
1. EAT suspension-+ 2-5 krad 30min [14C]TdR 8±3
at 370C for at 370C
30 min
2. EAT suspension -+ 6 pM BLEO 6 ltM BLEO [14C] TdR 18±3
at 370C 30 min 30 min
3. EAT suspension-+ 12 ,uMBLEO [14C] TdR 22
at 370C 60 min
4. EAT suspension -+ 12 pM BLEO 2-
-5 krad -+ 30 min [04C] TdR 28
at 370C 30 min at 370C
5. EAT suspension-+ 2* 5 krad -. 12 zMBLEO-+ [14C] TdR 30±2
at 37°C for 30 min
30 min
6. EAT suspension-+ 6 m BLEO-+ 2-5 krad -+6 /u BLEO- [14C] TdR 38±2
at 370C 30 min 30 min
In Treatment 5 and 6 BLEO was given 5 min after 2 * 5 krad exposure.
has an additive or less than additive effect
on the activity of the acid-insoluble
fraction from the lysed cells. However,
a drug dose of 10 ptg/ml given 30 min
beforeexposureto 2 5kradX-raystogether
with a further 10 ,ug/ml immediately after
radiation leads to a significantly greater
than additive effect.
A series ofexperiments followed (Fig. 3)
where the split drug dose technique was
used for various single radiation doses in
the range 1 2-7-5 krad. The results are
compared with those calculated for a
strictly additive effect, and suggest syner-
gistic action for each radiation dose
studied. The degree of synergism is
about the same at all radiation doses
studied, being 10-20% above the ex-
pected additive value.
DISCUSSION
The observed decrease in 14C activity
of the acid-soluble intracellular pool
(Figs 1, 2), compared to controls, in EAT
cells exposed to X-rays and subsequently
incubated in the presence of [14C]TdR
may reflect (a) decreased influx or
increased efflux rates ofTdR, (b) increased
rates of catabolism of [14C]TdR and
subsequent loss of label from the cell, or
(c) increased incorporation into the acid-
insoluble portion from the cell.
The latter case can be dismissed, as
results show (Table II) that the 14C
activity of the acid-insoluble fraction
decreases following exposure of the cells
to radiation. The other two possibilities
have been considered (Kwok and Chap-
man, 1977) and it has been shown that
thymidine catabolism tends to decrease
in cells exposed to X-rays. The decreased
14C activity of the intracellular pool is
observed as a result of reduction in TdR
influx rates, principally radiation-induced
inhibition offacilitated diffusion.
Bleomycin, in contrast to ionizing
radiation, appears to increase the size of
the intracellular 14C pool. This effect
may result from depression of DNA
synthesis rates, but is more likely to
involve an increase in the diffusion
characteristics of TdR entering the cell.
The experiments involving bleomycin
or radiation alone may be interpreted
to mean that, whilst these agents appear
to have opposing effects on the diffusion
characteristics of TdR entering the cell,
they both inhibit DNA synthesis as
observed by the decreased incorporation
of 14C into the acid-insoluble fraction
(Table II). The radiation effect is greater
than can be accounted for by the observed
decrease in activity of the intracellular
nucleoside and nucleotide pool. Hence
additive or greater than additive effects,
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FIG. 3.-Combined effects of BLEO
(2x 6 tiM) and X-rays (2-5 krad) on the
14C activity of the TCA-insoluble fraction
of cells incubated for 45 min at 37°C 0)
compared to the calculated sum of indivi-
dual treatment (x). Error bars represent
standard errors.
Combine* treatment
= EAT susp. at 37°C
+ 6 /tM BLEO 30 mm + X-rays
+ 6 HtM BLEO 30 min
+ [14C] TdR 45 min
Calculated sum of individual effects=
A + B.
A = EAT susp. at 37CC
+ 6 iMBLEO 30 min
+ 6 iM BLEO 30 min
+ [14C]TdR 45 min
B = EAT susp. at 37°C 30 min
+ X-rays + 30 min at 37°C
+ [14C]TdR 45 mins
as reported in Table II and Fig. 3, may
be related to the common site of action
on DNA rather than to plasma membrane
effects.
Combinations of single drug and single
radiation doses, reported in Table II,
produce additive or less than additive
effects for the rate of incorporation of
14C into DNA. The drug-induced inhibi-
tion observed here may involve depression
of enzyme activity associated with the
synthesis of DNA, binding to DNA
strands and thus hindering semi-conserv-
ative replication, or reduced replication
ratesfollowing drug-induced strandbreaks.
Ionizing radiation may act predominantly
by induction of strand breaks.
Synergistic action of bleomycin and
radiation could arise from the prevention
of repair of radiation-induced lesions by
the action of bleomycin (Miyaki and Ono,
1971; Punnonen, Rantanen and Gronroos,
1974). However, experiments involving
bleomycin added simultaneously orshortly
after exposure to X-rays (Table II) do
not suggest any synergistic action. Simi-
larly, synergism may arise through weak-
ening of DNA strands by bleomycin
binding, leading to more breaks per unit
volume induced by X-rays than would be
observed in cells exposed to X-rays alone.
The effect is not observed for the single
dose of bleomycin added before exposure
(Table II).
A possible explanation of the effective-
ness of the split drug dose plus radiation
treatment illustrated in Fig. 3 may
include the concept of the relatively short
biological half-life of bleomycin in EAT
cells, together with the low permeability
of cell plasma membranes to bleomycin.
Results from concurrent studies (Chapman
andAlalawi, 1977) showthat the biological
half-life of bleomycin in EAT cells is
approximately 1 h, and that intracellular
bleomycin at the steady state may
represent less than 1° ofthe extracellular
activity.
A hypothesis has been evolved propos-
ing that the intracellular fraction of the
drug added to the cell suspension before
radiation in the split-dose experiments
binds to DNA, weakening strands, result-
ing in radiation-induced free radical
damage not observed with radiation alone.
However, bleomycin from this first
dose is either physically unavailable
within the cell, perhaps bound to protein
(Chapman and Alalawi, 1976) or has been
catabolized so that it cannot subsequently
influence radiation-induced damage. A
second dose of pharmacologically active
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drug is required immediately after radia-
tion to "fix" drug-sensitized, radiation-
induced damage. The ability of bleomycin
to inhibit the action of the enzyme
ligase (Miyaki and Ono, 1971), poly-
merases and ATP synthesis (Punnonen et
at., 1974) may be involved in the apparent
effect of bleomycin mentioned earlier.
The net result may be more DNA
damage than is observed in either the
irradiated or the drug-treated controls,
leading to a further decrease in replication
rates. This decrease in replication is
observed as a synergistic action of bleo-
mycin and X-rays in reducing the rate of
[14C]TdR incorporation from the intra-
cellular pool into DNA following phos-
phorylation of the nucleoside.
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